These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9848894)

  • 1. Antenatal screening for syphilis. Still important in preventing disease.
    Welch J
    BMJ; 1998 Dec; 317(7173):1605-6. PubMed ID: 9848894
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of HIV and syphilis antenatal screening: a modelling study.
    Bristow CC; Larson E; Anderson LJ; Klausner JD
    Sex Transm Infect; 2016 Aug; 92(5):340-6. PubMed ID: 26920867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of integrated routine offering of prenatal HIV and syphilis screening in China.
    Owusu-Edusei K; Tao G; Gift TL; Wang A; Wang L; Tun Y; Wei X; Wang L; Fuller S; Kamb ML; Bulterys M
    Sex Transm Dis; 2014 Feb; 41(2):103-10. PubMed ID: 24413489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the operational costs of using rapid syphilis tests for the detection of maternal syphilis in Bolivia and Mozambique.
    Levin CE; Steele M; Atherly D; García SG; Tinajeros F; Revollo R; Richmond K; Díaz-Olavarrieta C; Martin T; Floriano F; Massango I; Gloyd S
    Sex Transm Dis; 2007 Jul; 34(7 Suppl):S47-54. PubMed ID: 17220812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost of routine antenatal screening for syphilis.
    Bryce RL; Pritchard RC
    Aust N Z J Obstet Gynaecol; 1981 Nov; 21(4):211-3. PubMed ID: 6951561
    [No Abstract]   [Full Text] [Related]  

  • 6. Modelling the cost-effectiveness of introducing rapid syphilis tests into an antenatal syphilis screening programme in Mwanza, Tanzania.
    Vickerman P; Peeling RW; Terris-Prestholt F; Changalucha J; Mabey D; Watson-Jones D; Watts C
    Sex Transm Infect; 2006 Dec; 82 Suppl 5(Suppl 5):v38-43. PubMed ID: 17215276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is antenatal syphilis screening still cost effective in sub-Saharan Africa.
    Terris-Prestholt F; Watson-Jones D; Mugeye K; Kumaranayake L; Ndeki L; Weiss H; Changalucha J; Todd J; Lisekie F; Gumodoka B; Mabey D; Hayes R
    Sex Transm Infect; 2003 Oct; 79(5):375-81. PubMed ID: 14573832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is routine antenatal screening for syphilis in Nigeria still justified clinically and economically?
    Bukar M; Audu BM; Takai UI; Ajayi BB; Kullima AA
    Saudi Med J; 2009 Oct; 30(10):1311-5. PubMed ID: 19838440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategic options for antenatal screening for syphilis in the United Kingdom: a cost effectiveness analysis.
    Connor N; Roberts J; Nicoll A
    J Med Screen; 2000; 7(1):7-13. PubMed ID: 10807140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative analysis of costs of single and dual rapid HIV and syphilis diagnostics: results from a randomised controlled trial in Colombia.
    Obure CD; Gaitan-Duarte H; Losada Saenz R; Gonzalez L; Angel-Muller E; Laverty M; Perez F
    Sex Transm Infect; 2017 Nov; 93(7):482-486. PubMed ID: 28495681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic profile of antenatal HIV testing: pharmaceutical and methodological considerations.
    Postma MJ; Beck EJ; Sprenger HG; de Jong-van den Berg LT
    AIDS; 2003 Mar; 17(5):755-7. PubMed ID: 12646801
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of antenatal screening for syphilis.
    Abyad A
    Health Care Women Int; 1995; 16(4):323-8. PubMed ID: 7649889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Positive results from serologic screening for syphilis in pregnancy in the Amsterdam region, 1991-1995].
    Bont J; Cairo I; van Doornum GJ; Coutinho RA; Bleker OP
    Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2312-5. PubMed ID: 10589219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syphilis control in pregnancy: decentralization of screening facilities to primary care level, a demonstration project in Nairobi, Kenya.
    Jenniskens F; Obwaka E; Kirisuah S; Moses S; Yusufali FM; Achola JO; Fransen L; Laga M; Temmerman M
    Int J Gynaecol Obstet; 1995 Jun; 48 Suppl():S121-8. PubMed ID: 7672171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socio-economic aspects of extended STD screening in pregnancy.
    Postma MJ; Jager JC; de Jong-van den Berg LT
    AIDS Care; 2000 Dec; 12(6):731-5. PubMed ID: 11177452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis.
    Zeuner D; Ades AE; Karnon J; Brown J; Dezateux C; Anionwu EN
    Health Technol Assess; 1999; 3(11):i-v, 1-186. PubMed ID: 10516927
    [No Abstract]   [Full Text] [Related]  

  • 17. Is antenatal screening for syphilis worth while?
    Gijsbers AJ; Whelan G
    Med J Aust; 1990 Mar; 152(5):276-7. PubMed ID: 2123961
    [No Abstract]   [Full Text] [Related]  

  • 18. Congenital syphilis in the 21st century.
    Carey JC
    Curr Womens Health Rep; 2003 Aug; 3(4):299-302. PubMed ID: 12844452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal screening for syphilis.
    Goh BT; Thornton AC
    Sex Transm Infect; 2007 Aug; 83(5):345-6. PubMed ID: 17693447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of on-site screening for syphilis among women attending a rural mobile antenatal clinic.
    Wilkinson D; Sach ME
    S Afr Med J; 1998; 88(6 Suppl):783-5. PubMed ID: 20593620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.